0000899243-23-018603.txt : 20230830
0000899243-23-018603.hdr.sgml : 20230830
20230830172414
ACCESSION NUMBER: 0000899243-23-018603
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210427
FILED AS OF DATE: 20230830
DATE AS OF CHANGE: 20230830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nant Capital, LLC
CENTRAL INDEX KEY: 0001675758
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37792
FILM NUMBER: 231226178
BUSINESS ADDRESS:
BUSINESS PHONE: 310-836-6400
MAIL ADDRESS:
STREET 1: 9922 JEFFERSON BOULEVARD
CITY: CULVER CITY
STATE: CA
ZIP: 90232
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NantHealth, Inc.
CENTRAL INDEX KEY: 0001566469
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
IRS NUMBER: 273019889
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 RDU CENTER DRIVE
STREET 2: SUITE 200
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 8559496288
MAIL ADDRESS:
STREET 1: 3000 RDU CENTER DRIVE
STREET 2: SUITE 200
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: Nant Health, LLC
DATE OF NAME CHANGE: 20130108
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-04-27
0
0001566469
NantHealth, Inc.
NH
0001675758
Nant Capital, LLC
450 DULEY ROAD
EL SEGUNDO
CA
90245
0
0
1
0
4.50% Convertible Senior Notes due
2026
2026-04-27
Common Stock
16242206
D
The Notes will be convertible at the option of the reporting persons at any time prior to the close of business on the business day immediately preceding the maturity date of the Notes. The Notes will be convertible into cash, shares of the issuer's common stock, or a combination thereof, at the issuer's election.
The initial conversion rate of the 4.50% Convertible Senior Notes due 2026 (the "Notes") is 259.8753 shares of common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $3.85 per share), subject to adjustment pursuant to the terms of the Notes. The conversion rate and conversion price have not been adjusted to reflect the Reverse Split (as defined below).
On December 15, 2022, the issuer effected a 1-for-15 reverse stock split (the "Reverse Stock Split") of its outstanding shares of common stock, par value $0.0001 per share ("Common Stock"). The numbers of shares reported on this Form 3 have not been adjusted to reflect the Reverse Split as it pertains to the number of shares of Common Stock that the reporting person beneficially owned as of the date that it became a reporting person.
/s/ Charles Kenworthy, Manager, Nant Capital, LLC
2023-08-30